Navigation Links
Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients

dopamine-producing nerve cells exhibit the progressive inability to initiate and control physical movements. There is currently no cure for Parkinson's disease.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the development of gene therapies for neurodegenerative disorders. Ceregene is in the clinic with CERE-110, an AAV2 based vector expressing nerve growth factor that is being tested as a treatment for Alzheimer's disease, and with CERE-120 for Parkinson's disease. CERE-130 is in late preclinical development for ALS. Ceregene was launched in January 2001 and is a former subsidiary of Cell Genesys, Inc. , which is headquartered in South San Francisco, CA. Ceregene's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, as well as Hamilton BioVentures and, California Technology Partners.

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded more than $90 million in research to date, either directly or through partnerships.

CONTACT: Jeffrey M. Ostrove, Ph.D., President and CEO of Ceregene, Inc.,+1-858-458-8808

Web site: http://www.ceregene.com/

Ticker Symbol: (NASDAQ-NMS:CEGE)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

Post Your Comments:
(Date:11/28/2009)...re/ -- Siemens Healthcare redefines productivity ...aging matrix) technology and with its new Dot(TM) ...ies are introduced in the new MAGNETOM ® Aer...anners at the 95th Scientific Assembly and Annual ...ca (RSNA) from November 29 to December 3 at McCorm...
(Date:11/27/2009)...wire/ -- At the upcoming Radiological Society of N..., Royal Philips Electronics ( PHG, AEX: PHI) will ...informatics solutions designed to directly address... delivering meaningful imaging innovations that re... easy upgradability. This focus will enable Phili...
(Date:11/25/2009)... Heska Corporation ( HSKA...gnostic and specialty products to the veterinary i...gnostics Corporation for the supply of blood gas p...ary market. ,, (Logo: http://www.newscom.c...and Roche share the same passion for innovating in...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3IOF AMGEN Health Professional Awareness Grants awarded at Beijing conference 10092 1IOF AMGEN Health Professional Awareness Grants awarded at Beijing conference 10092 2Forest Service Web based tool helps manage environmental risk 10090 1Forest Service Web based tool helps manage environmental risk 10090 2NIH announces 115 awards to encourage high risk research and innovation 10088 1NIH announces 115 awards to encourage high risk research and innovation 10088 2
...sdaq: NGSX ) announced today that it has complete...cal trial of its lead product candidate,NGX-4010 f...yneuropathy,(HIV-DSP). NGX-4010 is a dermal patch ...eviously completed Phase 3 trials demonstrated tha...10 applied directly to the,site of pain may provid...
...f Vical Incorporated (Nasdaq: VICL ), announced o...linical trial of its NV1FGF,angiogenesis therapy, ...echnology. Assuming successful completion of the t...e for marketing approval in 2010. The plasmid DNA...,(FGF-1), a growth factor that stimulates the grow...
Other Medicine Technology:NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 2NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 3NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 4Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 2Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 3
(Date:11/29/2009)...Using mannequins to teach doctors-in-training how ... way to improve their skills without compromising ...from Henry Ford Hospital. , The study shows that...luable tool to improve medical residents, knowledg... the more common ultrasound-guided procedures, inc...
(Date:11/29/2009)...eone get blamed for something leads to more self-d..., SUNDAY, Nov. 29 (HealthDay News) -- The blame ga...when the target is innocent. , Researchers foun...for a problem, even if it,s an unfair accusation, ...rs, too. , "When we see others protecting thei...
(Date:11/29/2009)... "The YogaForce A-Line Athletic Ma...r. Andrew Weil, M.D., author and physician best kn... integrative medicine. Go to www.yogaforce.com ... on the gift list. , San ... time for the holidays, the YogaForce newly patent...
(Date:11/28/2009)...CHICAGO, Nov. 28 Get ready for ...n the clinical routine when Siemens introduces...bly and Annual Meeting of the Radiological Society...ber 3 at McCormick Place (Booth #825, East Buildin...go. via , Siemens, new imaging software for m...
(Date:11/28/2009)...tips to help lift spirits, recognize signs of depr...News) -- For many seniors, the holiday season can ...ones, struggle with health issues or worry about m...s Society. , To help overcome the seasonal blue...he following advice: , Get out and socialize or ...
Breaking Medicine News(10 mins):Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:When Accusations Start to Fly, They Multiply 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2
...dicts Ten Emerging Technologies That Will Shape He...r, CLEVELAND, Nov. 12 Imagine if a simple blood ...also predicting a patient,s,prognosis. Imagine if ...vested organs alive until they,re transplanted in,...
...er satisfaction survey shows health improvements, ...benefits of plan -, SAN ANTONIO, Nov. 12 One yea...percent of members of Care Improvement Plus feel,t...health has improved, 97 percent cite Care Improvem...
... half of people diagnosed with high blood pressure...iagnosed, according to research carried out at the...cio from Warwick Medical School at the University ... Hypertension is an important cause of serious dis...
...Nov. 12 The Service Employees,International Union...th,care workers, issued the following statement in...mending our broken health care system released by,...re costs as their number one,economic concern -- S...
...astest Growing Private Company* Delivers Quality, ...ecialize in Patients, Needs -, GLENDALE, Calif., ... through 2007) earned it the status as one of the ... for,its healthcare organization: Lakeside Communi...
...lly-Friendly Car Donation Program Extends Life of ... 12 It,s too big to fit in the,blue plastic bin a...about,recycling as you join thousands of Americans...ch runs the Kidney Cars,Program., Over the course...
Other Medicine News:Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 2Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 3Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 4Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 5Health News:Texas Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2Health News:SEIU Statement in Support of New Blueprint to Solve Health Care Crisis by Senator Max Baucus 2Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 2Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 3Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 4Health News:Kidney Cars Celebrates America Recycles Day 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: